September 2nd 2023
From new research on psilocybin as a treatment for MDD to new FDA approvals for ADHD and BED, here are highlights from the week in Psychiatric Times.
5th Annual International Congress on the Future of Neurology®
Register Now!
2022 Annual Psychiatric Times™ World CME Conference™ - Day Two
View More
2022 Annual Psychiatric Times™ World CME Conference™ - Day Three
View More
2022 Annual Psychiatric Times™ World CME Conference™ - Day One
View More
Recognizing Rett Syndrome Early to Improve Long-Term Management Outcomes
Register Now!
Shaping the Management of Multiple Sclerosis – The Potential for BTK Inhibitors in Clinical Practice
View More
Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors
10/13/2023
Register Now!
2023 Annual Psychiatric Times™ World CME Conference
View More
From Clinical Trials to Clinical Practice – Incorporating Screening and Assessment Strategies for the Early Diagnosis of Alzheimer Disease
View More
Taking Pompe Disease Management to the Next Level: Optimizing Clinical Assessments and Treatment Decision-Making
View More
Addressing Healthcare Inequities in Stroke Care: How Can We Play an Active Role in Improving Outcomes for All Patients?
View More
2022 4th Annual International Congress on the Future of Neurology
View More
Understanding Best Care Practices for Hemorrhagic Stroke – A Focus on the Role of DOAC Reversals
View More
Clinical Consultations™: Integrating Modern Antipsychotic Medications into the Management of Patients with Schizophrenia
View More
Collaborating Across the Continuum™ : Managing Relapsing MS – A Focus on the Utility of CD20-Targeted B-Cell Therapy
View More
Patient, Provider, and Caregiver Connection™: Challenges in Diagnosis and Management for Patients with ADHD During the COVID-19 Pandemic
View More
Expert Illustrations & Commentaries™: A Family Physicians’ Guide to Migraine Treatment – Emerging Therapies and Evolving Paradigms
View More
PER® Postgame™: MS Meeting Updates – Integrating the Latest Data to Optimize Care in the COVID-19 Era
View More
Medical Crossfire®: What Strategies Can the Care Team Implement to Optimize the Management of Pediatric Patients with NF1?
View More
Expert Illustrations & Commentaries™: Visualizing the Role of Antipsychotics in the Management of Schizophrenia: What is the Role of TAAR1?
View More
Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment
View More
BURST CME™: Taking ALS Management to the Next Level
View More
FAQs in MS: Exploring Provocative Questions From MS Meeting Updates
View More
The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease
View More
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
Improving Care for Patients with Motor Complications of Parkinson Disease: Role of Technology and Data
View More
Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis
View More
Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia
View More
Advances In™ Schizophrenia: Expanding the Therapeutic Landscape
View More
Advances In Treating Migraine in Your OB/GYN Practice: Navigating Treatment Paradigms to Improve Patient Care
View More
How Anxiety and Habits Contribute to Anorexia Nervosa
September 30th 2019Anorexia nervosa (AN) is a severe and debilitating illness with one of the highest mortality rates of any psychiatric disorder. The illness course is often long, recovery is slow, and the rates of full recovery are low.
Read More
Interoception in Eating Disorders: A Clinical Primer
September 30th 2019More than two-thirds of patients with eating disorders also have comorbid mood and anxiety disorders. This article considers how a transdiagnostic process called interoception may help to advance our understanding and treatment of eating disorders.
Read More
Closing the Research-Practice Gap in Eating Disorders
September 30th 2019Eating disorders (EDs) are associated with high medical and psychiatric comorbidity, poor quality of life, and high mortality, and mortality from anorexia nervosa (AN) is the highest of all mental disorders. Fortunately, there are a number of evidence-based psychological treatment approaches for EDs.
Read More
Special Report Countdown: Comorbidities
July 14th 2015Patients with psychiatric disorders, particularly schizophrenia, anorexia nervosa, and substance use disorders, have reduced life expectancies compared with the general population. This and other facts emphasize the need for the latest clinical information, highlighted in this countdown.
Read More
Eating Disorders: Understanding Anorexia Nervosa
May 6th 2014How are individuals with anorexia nervosa able to ignore signals regarding hunger that otherwise motivate eating, even when they are severely emaciated? Expert insights and online coverage by Psychiatric Times during National Eating Disorders Awareness Week.
Read More